Pmv Net Tangible Assets from 2010 to 2024
| PMVP Stock | USD 1.60 0.01 0.63% |
Net Tangible Assets | First Reported 2010-12-31 | Previous Quarter 282.9 M | Current Value 175.4 M | Quarterly Volatility 162 M |
Check Pmv Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pmv Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 4.5 K, Net Interest Income of 10.3 M or Interest Income of 10.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.69. Pmv financial statements analysis is a perfect complement when working with Pmv Pharmaceuticals Valuation or Volatility modules.
Pmv | Net Tangible Assets |
Latest Pmv Pharmaceuticals' Net Tangible Assets Growth Pattern
Below is the plot of the Net Tangible Assets of Pmv Pharmaceuticals over the last few years. It is the total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. Pmv Pharmaceuticals' Net Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pmv Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Net Tangible Assets | 10 Years Trend |
|
Net Tangible Assets |
| Timeline |
Pmv Net Tangible Assets Regression Statistics
| Arithmetic Mean | 59,084,459 | |
| Geometric Mean | 85,190,995 | |
| Coefficient Of Variation | 274.13 | |
| Mean Deviation | 143,543,812 | |
| Median | (46,140,000) | |
| Standard Deviation | 161,967,899 | |
| Sample Variance | 26233.6T | |
| Range | 429.6M | |
| R-Value | 0.75 | |
| Mean Square Error | 12501.4T | |
| R-Squared | 0.56 | |
| Significance | 0 | |
| Slope | 27,041,746 | |
| Total Sum of Squares | 367270.4T |
Pmv Net Tangible Assets History
About Pmv Pharmaceuticals Financial Statements
Pmv Pharmaceuticals shareholders use historical fundamental indicators, such as Net Tangible Assets, to determine how well the company is positioned to perform in the future. Although Pmv Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Pmv Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Pmv Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Tangible Assets | 282.9 M | 175.4 M |
Pair Trading with Pmv Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Pmv Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Pmv Stock
| 0.66 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.59 | PEPG | PepGen | PairCorr |
| 0.54 | NKTX | Nkarta Inc Buyout Trend | PairCorr |
| 0.51 | FDMT | 4D Molecular Therapeutics | PairCorr |
| 0.48 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
The ability to find closely correlated positions to Pmv Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pmv Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pmv Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pmv Pharmaceuticals to buy it.
The correlation of Pmv Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pmv Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pmv Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Pmv Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Pmv Stock Analysis
When running Pmv Pharmaceuticals' price analysis, check to measure Pmv Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv Pharmaceuticals is operating at the current time. Most of Pmv Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pmv Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pmv Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.